The new method, published in npj Vaccines, analyzes the vaccine vial label and its adhesive and therefore allows the vaccine vials to be retained in the supply chain. Furthermore, the study has ...

Seventy-five percent of all COVID-19 vaccine trials around the world are using Schott's glass vials, according to the manufacturer. To meet the growing demand, their employees are working around ...

As the world waits for COVID-19 vaccines, some pharmaceutical companies stand armed and ready with an exciting improvement: better vials to hold the doses. Vials haven’t changed much in the last ...

MDV: Multidose vial; NA: Not available ... influenza vaccination campaign estimated that the total time to get a vaccine ready to be administered per patient was 87 s for MDVs and 49.71 s for ...